Thoratec, St. Jude Medical deal

St. Jude will acquire diagnostic and cardiovascular company Thoratec for $63.50 per share in cash, in a deal the companies say is valued at about $3.4 billion net of cash. The price is a 35% premium to Thoratec’s close of $46.89 on July 17, the last trading day before rumors of the acquisition surfaced, and a 10% premium to Thoratec’s close of $57.58 on July 21, the day before the deal was announced. ...